Document Detail


Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient.
MedLine Citation:
PMID:  12371635     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) both for attacks and for prevention of secondary amyloidosis. The overall non-responder rate varies from 5-10 to 40%. Thalidomide is known to blunt the acute phase response. We report the efficacy of the addition of thalidomide to colchicine in controlling the febrile attacks and acute phase response in a patient with FMF resistant to 2 mg colchicine per day.
Authors:
E Seyahi; H Ozdogan; S Masatlioglu; H Yazici
Related Documents :
19235105 - Evaluation of the function of the vestibular system in patients with migraine.
16538425 - High prolactin levels as a worsening factor for migraine.
24458895 - Predictive value of upper-limb accelerometry in acute stroke with hemiparesis.
2522805 - Outpatient myelography: an acceptable and cost-effective technique.
19235105 - Evaluation of the function of the vestibular system in patients with migraine.
7469835 - Eeg in phenylketonuria. attempt to establish clinical importance of eeg changes.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  20     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:    2002 Jul-Aug
Date Detail:
Created Date:  2002-10-09     Completed Date:  2003-06-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  S43-4     Citation Subset:  IM    
Affiliation:
Department of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Colchicine / therapeutic use*
Drug Therapy, Combination
Familial Mediterranean Fever / drug therapy*
Humans
Immunosuppressive Agents / therapeutic use*
Male
Middle Aged
Thalidomide / therapeutic use*
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 50-35-1/Thalidomide; 64-86-8/Colchicine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adamantiades-Behçet's disease with inner ear involvement.
Next Document:  Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis.